"After white nationalist and alt-right poster boy Milo Yiannopoulos landed a massive book deal with a reported $250,000 advance, publisher Simon & Schuster has come under harsh criticism from those concerned that a book will elevate the voice of the notorious Breitbart editor", wrote USA Today's Kelly Lawler in her original article.
Yiannopoulous was banned from Twitter in July past year after he encouraged people to troll Jones, as her role in a female reboot of Ghostbusters was earned her huge attention.
The publisher had issued a statement distancing itself from Yiannopoulos' views, saying it had "never condoned discrimination or hate speech in any form" but published "a wide range of authors with greatly varying and frequently controversial opinions".
A spokesperson told The Bookseller that the United Kingdom division of S&S has no plans to publish the autobiographical book, entitled risky. It has not yet responded to the Standard's request for comment.
The criticism appears to have backfired, however, as the book, called risky, has reached Amazon's bestseller list two months before it is published.
Yiannopoulos confirmed the news to The Hollywood Reporter last week telling the outlet: 'Did it hurt Madonna being banned from MTV in the 1990s?
"I don't regret (the decision), but it is an imperfect solution", Morgan said. "Just as I predicted, the opposite has happened", he told the magazine. I thought they were going to have me escorted from the building - but, instead, they offered me a wheelbarrow full of money. Jones, understandably, is now among those criticizing the decision to give Yiannopoulos a forum.
Writers like Sarah Silverman, Rainbow Rowell, and Danielle Henderson also spoke out against the deal, but that is not stopping the Breitbart News editor who is continuing his fight for freedom of speech by publishing a book about free speech.
Another black writer with Simon & Schuster and radio host, Karen Hunter, said she was "rethinking my relationship" with the publisher.
Opko Health, Inc. (OPK) Given "Buy" Rating at Laidlaw
Finally, Jaffetilchin Investment Partners LLC boosted its position in shares of Opko Health by 1.2% in the second quarter. According to sentiments of 5 analysts the company is expected to report revenues of $310.82M for the current quarter.